Similarly, advanced oxidative protein products (AOPPs) can increase ERK, JNK, and p38 phosphorylation levels in AF cells and induce cellular senescence through the p53/p21 pathway, whereas intervention with pathway inhibitors ameliorates AOPP-induced senescence in AF cells [70]. The gene discussed is MAPK8; the disease is atrial fibrillation.